Deletion of murine Rhoh leads to de-repression of Bcl-6 via decreased KAISO levels and accelerates a malignancy phenotype in a murine model of lymphoma

References

• Hodge RG, Ridley AJ. Regulating Rho GTPases and their regulators. Nat Rev Mol Cell Biol. 2016;17:496–510.
   PubMed Web of Science ®Google Scholar
• Dallery E, Galiegue-Zouitina S, Collyn-d’Hooghe M, et al. TTF, a gene encoding a novel small G protein, fuses to the lymphoma- associated LAZ3 gene by t(3;4) chromosomal translocation. Oncogene. 1995;10:2171–2178.
   PubMed Web of Science ®Google Scholar
• Preudhomme C, Roumier C, Hildebrand MP, et al. Nonrandom 4p13 rearrangements of the RhoH/TTF gene, encoding a GTP- binding protein, in non-Hodgkin’s lymphoma and multiple myeloma. Oncogene. 2000;19:2023–2032.
   PubMed Web of Science ®Google Scholar
• Pasqualucci L, Neumeister P, Goossens T, et al. Hypermutation of multiple proto-oncogenes in B-cell diffuse large-cell lymphomas. Nature. 2001;412:341–346.
   PubMed Web of Science ®Google Scholar
• Troeger A, Williams DA. Hematopoietic-specific Rho GTPases Rac2 and RhoH and human blood disorders. Exp Cell Res. 2013;319:2375–2383.
   PubMed Web of Science ®Google Scholar
• Gu Y, Chae H, Siefring J, et al. RhoH, a GTPase recruits and activates Zap70 required for T cell receptor signaling and thymocyte development. Nat Immunol. 2006;7:1182–1190.
   PubMed Web of Science ®Google Scholar
• Chae HD, Lee KE, Williams DA, et al. Cross-talk between RhoH and Rac1 in regulation of actin cytoskeleton and chemotaxis of hematopoietic progenitor cells. Blood. 2008;111:2597–2605.
   PubMed Web of Science ®Google Scholar
• Iwasaki T, Katsumi A, Kiyoi H, et al. Prognostic implication and biological roles of RhoH in acute myeloid leukaemia. Eur J Haematol. 2008;81:454–460.
   PubMed Web of Science ®Google Scholar
• Sanchez-Aguilera A, Rattmann I, Drew DZ, et al. Involvement of RhoH GTPase in the development of B-cell chronic lymphocytic leukemia. Leukemia. 2010;24:97–104.
   PubMed Web of Science ®Google Scholar
• Gundogdu MS, Liu H, Metzdorf D, et al. The haematopoietic GTPase RhoH modulates IL3 signalling through regulation of STAT activity and IL3 receptor expression. Mol Cancer. 2010;9:225.
   PubMed Web of Science ®Google Scholar
• Troeger A, Johnson AJ, Wood J, et al. RhoH is critical for cell-microenvironment interactions in chronic lymphocytic leukemia in mice and humans. Blood. 2012;119:4708–4718.
   PubMed Web of Science ®Google Scholar
• Fueller F, Kubatzky KF. The small GTPase RhoH is an atypical regulator of haematopoietic cells. Cell Commun Signal. 2008;6:6.
   PubMedGoogle Scholar
• Hiraga J, Katsumi A, Iwasaki T, et al. Prognostic analysis of aberrant somatic hypermutation of RhoH gene in diffuse large B cell lymphoma. Leukemia. 2007;21:1846–1847.
   PubMed Web of Science ®Google Scholar
• Zhang B, Zhang Y, Shacter E. Rac1 inhibits apoptosis in human lymphoma cells by stimulating Bad phosphorylation on Ser-75. Mol Cell Biol. 2004;24:6205–6214.
   PubMed Web of Science ®Google Scholar
• Gu Y, Jasti AC, Jansen M, et al. RhoH, a hematopoietic-specific Rho GTPase, regulates proliferation, survival, migration, and engraftment of hematopoietic progenitor cells. Blood. 2005;105:1467–1475.
   PubMed Web of Science ®Google Scholar
• Krivtsov AV, Feng Z, Lemieux ME, et al. H3K79 methylation profiles define murine and human MLL-AF4 leukemias. Cancer Cell. 2008;14:355–368.
   PubMed Web of Science ®Google Scholar
• Cattoretti G, Pasqualucci L, Ballon G, et al. Deregulated BCL6 expression recapitulates the pathogenesis of human diffuse large B cell lymphomas in mice. Cancer Cell. 2005;7:445–455.
   PubMed Web of Science ®Google Scholar
• Hans CP, Weisenburger DD, Greiner TC, et al. Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray. Blood. 2004;103:275–282.
   PubMed Web of Science ®Google Scholar
• Mino A, Troeger A, Brendel C, et al. RhoH participates in a multi-protein complex with the zinc finger protein kaiso that regulates both cytoskeletal structures and chemokine-induced T cells. Small GTPases. 2018;9:260–273.
   PubMedGoogle Scholar
• Koh DI, Yoon JH, Kim MK, et al. Kaiso is a key regulator of spleen germinal center formation by repressing Bcl6 expression in splenocytes. Biochem Biophys Res Commun. 2013;442:177–182.
   PubMed Web of Science ®Google Scholar
• Shaffer AL, Yu X, He Y, et al. BCL-6 represses genes that function in lymphocyte differentiation, inflammation, and cell cycle control. Immunity. 2000;13:199–212.
   PubMed Web of Science ®Google Scholar
• Fearon DT, Manders P, Wagner SD. Arrested differentiation, the self-renewing memory lymphocyte, and vaccination. Science. 2001;293:248–250.
   PubMed Web of Science ®Google Scholar
• Mandelbaum J, Bhagat G, Tang H, et al. BLIMP1 is a tumor suppressor gene frequently disrupted in activated B cell-like diffuse large B cell lymphoma. Cancer Cell. 2010;18:568–579.
   PubMed Web of Science ®Google Scholar
• Crequer A, Troeger A, Patin E, et al. Human RHOH deficiency causes T cell defects and susceptibility to EV-HPV infections. J Clin Invest. 2012;122:3239–3247.
   PubMed Web of Science ®Google Scholar
• Chai N, Chang HE, Nicolas E, et al. Assembly of hepatitis B virus envelope proteins onto a lentivirus pseudotype that infects primary human hepatocytes. J Virol. 2007;81:10897–10904.
   PubMed Web of Science ®Google Scholar
• Galiegue-Zouitina S, Delestre L, Dupont C, et al. Underexpression of RhoH in Hairy Cell Leukemia. Cancer Res. 2008;68:4531–4540.
   PubMed Web of Science ®Google Scholar
• Prokhortchouk A, Hendrich B, Jorgensen H, et al. The p120 catenin partner Kaiso is a DNA methylation-dependent transcriptional repressor. Genes Dev. 2001;15:1613–1618.
   PubMed Web of Science ®Google Scholar
• Yoon HG, Chan DW, Reynolds AB, et al. N-CoR mediates DNA methylation-dependent repression through a methyl CpG binding protein Kaiso. Mol Cell. 2003;12:723–734.
   PubMed Web of Science ®Google Scholar
• Daniel JM, Spring CM, Crawford HC, et al. The p120(ctn)-binding partner Kaiso is a bi-modal DNA-binding protein that recognizes both a sequence-specific consensus and methylated CpG dinucleotides. Nucleic Acids Res. 2002;30:2911–2919.
   PubMed Web of Science ®Google Scholar
• Daniel JM, Ireton RC, Reynolds AB. Monoclonal antibodies to Kaiso: a novel transcription factor and p120ctn-binding protein. Hybridoma. 2001;20:159–166.
   PubMedGoogle Scholar
• Daniel JM, Reynolds AB. The catenin p120(ctn) interacts with Kaiso, a novel BTB/POZ domain zinc finger transcription factor. Mol Cell Biol. 1999;19:3614–3623.
   PubMed Web of Science ®Google Scholar
• Koh DI, Han D, Ryu H, et al. KAISO, a critical regulator of p53-mediated transcription of CDKN1A and apoptotic genes. Proc Natl Acad Sci U S A. 2014;111:15078–15083.
   PubMed Web of Science ®Google Scholar
• Koh DI, An H, Kim MY, et al. Transcriptional activation of APAF1 by KAISO (ZBTB33) and p53 is attenuated by RelA/p65. Biochim Biophys Acta. 2015;1849:1170–1178.
   PubMed Web of Science ®Google Scholar
• Blattler A, Farnham PJ. Cross-talk between site-specific transcription factors and DNA methylation states. J Biol Chem. 2013;288:34287–34294.
   PubMed Web of Science ®Google Scholar
• Reljic R, Wagner SD, Peakman LJ, et al. Suppression of signal transducer and activator of transcription 3-dependent B lymphocyte terminal differentiation by BCL-6. J Exp Med. 2000;192:1841–1848.
   PubMed Web of Science ®Google Scholar
• Tunyaplin C, Shaffer AL, Angelin-Duclos CD, et al. Direct repression of prdm1 by Bcl-6 inhibits plasmacytic differentiation. J Immunol. 2004;173:1158–1165.
   PubMed Web of Science ®Google Scholar
• Troeger A, Chae HD, Senturk M, et al. A unique carboxyl-terminal insert domain in the hematopoietic-specific, GTPase-deficient Rho GTPase RhoH regulates post-translational processing. J Biol Chem. 2013;288:36451–36462.
   PubMed Web of Science ®Google Scholar